Page 180 - FBL AR 2019-20
P. 180

Fermenta Biotech Limited
           Annual Report 2019-20



                 ( H in Lakhs )  March 31, 2019   229.32    -      229.32    458.64   ( H in Lakhs )  Total  13,313.86  (22.15)  11,747.48  52.80  (138.25)  (229.32)  (148.61)  24,575.81  5,952.02  554.69  (719.84)  (72.26)  (961.58)  173.57  29,502.41




                                   Non   Controlling   Interest  1,098.36  (1,098.70)  2.16  -  -  -  -  1.82  (0.58)  -  -  -  -  -  1.24

                        22.15
                   March 31, 2020   458.64    961.58    1,442.37   Attributable   to the Owners   of the Parent   Company  12,215.50  9.26  1,076.55  -  11,745.32  -  52.80  -  (138.25)  -  (229.32)  -  (148.61)  2.57  24,573.99  11.83  5,952.60  -  554.69  -  (719.84)  -  (72.26)  -  (961.58)  -  173.57  11.34  29,501.17  23.17





                                   Items of other comprehensive   income  Equity  Foreign currency   instruments   translation   through OCI  reserve  -  -  -  -  -  -  -  -  -  -  -  -  -  (8.33)  (8.33)











                                      Retained   earnings  10,501.77  2.35  11,745.32  -  (138.25)  -  (151.18) @  21,960.01  5,952.60  -  (719.84)  (72.26)  -  170.56 @  27,291.07  Prashant Nagre  Chief Executive Officer

            Consolidated Statement of changes in equity for the year ended March 31, 2020
                                            -  -  -  52.80  -  -  -  52.80  -  554.69  -  -  -  -  607.49
                                      Share options   outstanding   account




                                      General   reserve  4,736.70  -  -  -  -  -  -  -  -  (229.32)  -  -  -  4,507.38  -  -  -  -  -  -  -  -  (961.58)  -  -  -  3,545.80  Satish Varma   Executive Director   Srikant N. Sharma  Company Secretary


                                   Reserves and surplus  Unrealised   gain/(loss) on   dilution  (4,242.23)  (4,242.23)  (4,242.23)  Fermenta Biotech Limited (Formerly known as DIL Limited)





                                      Capital   redemption   reserve  70.00  -  -  -  -  -  -  70.00  -  -  -  -  -  -  70.00  For and on behalf of the Board of Directors of


                                            -  1,074.20  -  -  -  -  -  1,074.20  -  -  -  -  -  -  1,074.20  Chief Financial Officer   Thane, August 28, 2020
                                      Capital reserve   pursuant to   amalgamation             Krishna Datla   Managing Director   Sumesh Gandhi





                                      Capital   reserve  1,140.00  -  -  -  -  -  -  1,140.00  -  -  -  -  -  -  1,140.00



                (a)  Equity share capital  Balance at the beginning of the year Add: Issue of shares pursuant to scheme of amalgamation (Refer note 1.2)  Add: Issue of Bonus shares Balance at the end of the year  (b) Other equity  Balance as at April 01, 2018 Pursuant to scheme for amalgamation    (Refer note 1.2)  Profit for the year Recognition of share based payments Payment of dividend (including dividend   distribution tax) Utilised for issue of bonus shares Other co















          178                                                                                    Partner
   175   176   177   178   179   180   181   182   183   184   185